Article citationsMore>>

Beaton, D.E., Katz, J.N., Fossel, A.H., Wright, J.G., Tarasuk, V. and Bombardier, C. (2001) Measuring the Whole or the Parts? Validity, Reliability, and Responsiveness of the Disabilities of the Arm, Shoulder and Hand Outcome Measure in Different Regions of the Upper Extremity. Journal of Hand Therapy, 14, 128-142.
https://doi.org/10.1016/s0894-1130(01)80043-0

has been cited by the following article:

• TITLE: Application of the Theory of Planned Behavior in Patients with Breast Cancer-Related Lymphedema

  AUTHORS: Xue Hu

  KEYWORDS: Breast Cancer, Lymphedema, Theory of Planned Behavior, Nursing Behavior, Management Efficacy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.14 No.8, August 11, 2026

  ABSTRACT: Objective: To investigate the application effect of self-care intervention based on planned behavior theory in patients with breast cancer-related lymphedema. Methods: Using convenience sampling method, 84 patients with breast cancer-related lymphedema from a tertiary Grade A hospital in Jingzhou City from June 2024 to December 2025 were selected as study subjects and divided into a control group and an experimental group, with 42 cases in each group. The control group received conventional health education, while the experimental group received planned behavior theory-based self-care intervention in addition to the control group’s routine care. The intervention lasted for 3 months. The self-management efficacy, breast cancer lymphedema-related symptoms, and upper limb function scores were compared between the two groups before and after intervention. Results: A total of 84 patients completed follow-up, with 42 in each group. Following the intervention, the experimental group achieved better scores than the control group in self-management efficacy, lymphedema symptoms, and upper limb function (P Conclusion: This study indicates that a self-care intervention grounded in the theory of planned behavior improved self-management efficacy and symptom control in patients with breast cancer-related lymphedema. The follow-up period was limited to three months; whether these effects persist remains to be established.